Search research articles
Contact Us
Filters
Showing results (141-150 of 167) with videos related to
Page
of 17
Sort By:
Journal of Proteome Research
|
May 17, 2019
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy
J Patrick Murphy, Youra Kim, Derek R Clements, et al.
Journal of Proteome Research
|
March 1, 2017
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies
J Patrick Murphy, Prathyusha Konda, Daniel J Kowalewski, et al.
Leukemia
|
August 6, 2014
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
C Berlin, D J Kowalewski, H Schuster, et al.
Leukemia
|
April 7, 2016
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
C Berlin, D J Kowalewski, H Schuster, et al.
Blood Cancer Journal
|
April 9, 2016
Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini
D J Kowalewski, S Walz, L Backert, et al.
Oncoimmunology
|
April 11, 2018
HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy
Annika Nelde, Daniel J Kowalewski, Linus Backert, et al.
The Journal of Experimental Medicine
|
August 18, 2018
Identification of non-mutated neoantigens presented by TAP-deficient tumors
Koen A Marijt, Laura Blijleven, Els M E Verdegaal, et al.
Plos One
|
November 29, 2016
Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy
Sharon M Barth, Christian M Schreitmüller, Franziska Proehl, et al.
Analytical Chemistry
|
February 20, 2019
Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin
J Patrick Murphy, Qijia Yu, Prathyusha Konda, et al.
Proteomics
|
March 6, 2018
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target Selection
Jens Fritsche, Barbara Rakitsch, Franziska Hoffgaard, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 167) with videos related to
Sort By:
Page
of 17
Journal of Proteome Research
|
May 17, 2019
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy
J Patrick Murphy, Youra Kim, Derek R Clements, et al.
Journal of Proteome Research
|
March 1, 2017
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies
J Patrick Murphy, Prathyusha Konda, Daniel J Kowalewski, et al.
Leukemia
|
August 6, 2014
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
C Berlin, D J Kowalewski, H Schuster, et al.
Leukemia
|
April 7, 2016
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
C Berlin, D J Kowalewski, H Schuster, et al.
Blood Cancer Journal
|
April 9, 2016
Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini
D J Kowalewski, S Walz, L Backert, et al.
Oncoimmunology
|
April 11, 2018
HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy
Annika Nelde, Daniel J Kowalewski, Linus Backert, et al.
The Journal of Experimental Medicine
|
August 18, 2018
Identification of non-mutated neoantigens presented by TAP-deficient tumors
Koen A Marijt, Laura Blijleven, Els M E Verdegaal, et al.
Plos One
|
November 29, 2016
Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy
Sharon M Barth, Christian M Schreitmüller, Franziska Proehl, et al.
Analytical Chemistry
|
February 20, 2019
Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin
J Patrick Murphy, Qijia Yu, Prathyusha Konda, et al.
Proteomics
|
March 6, 2018
Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target Selection
Jens Fritsche, Barbara Rakitsch, Franziska Hoffgaard, et al.
Page
of 17